Stock Events

Stock Events

CRISPR Therapeutics (C2RS34.SA) Q3 2025 Earnings

4AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-13.19

-9.64

-6.09

-2.54

Details

Expected EPS

-7.7029435369

Actual EPS

-13.19064

Surprise EPS

-5.49

Surprise Percent

+71.24%

Description

CRISPR Therapeutics (C2RS34.SA) has reported earnings of -13.19064 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.